The remodeling involves a particular increase in a cancer-associated fibroblast subtype, i.e., FAP+ fibroblasts, and a decrease in a mesenchymal stem-like cell subtype, i.e., NT5E+ fibroblasts. The gene discussed is NT5E; the disease is cancer.